{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/karyopharm-reports-second-quarter-2026-financial-results-and-highlights-continued-progress-toward-myelofibrosis-snda-submission-302850269.html", "message": "News view counter 880659 successfully enlarged"}